RTOG 0436: A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin and Radiation for Patients with Esophageal Cancer who are Treated without Surgery
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 16 Mar 2018
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Paclitaxel
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 14 Feb 2018 Planned End Date changed from 1 Aug 2018 to 1 Apr 2020.
- 30 May 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
- 18 Feb 2014 Primary endpoint 'Overall-survival-rate' has not been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History